The key role of insulin resistance in the atherogenic dyslipidemia of the metabolic syndrome (29) raises the possibility that concordant changes in MT1-MMP-mediated generation of sIR and sLDLR might have contributed to the relationships observed between sLDLR and the lipoprotein components of this dyslipidemia. The gene discussed is MMP14; the disease is metabolic syndrome.